nov. 11, 2020
Important Announcement APTT Reference Range Changes
Effective midnight Tuesday, November 17, 2020, ACL Laboratories will standardize to a new lot of coagulation reagents and will begin using a new reference range, therapeutic range, and critical value for Activated Partial Thromboplastin Time (Test Order Code APTT).
Read more
aug. 17, 2020
National Shortage of Aptima Unisex Collection Kits
Due to the wide spread use of these collection devices, there is a national shortage of Aptima® Unisex collection devices used primarily for Chlamydia, Gonorrhea and/or Trichomonas laboratory testing.
Please read the attached document for additional information and alternative collection devices acceptable for Chlamydia and/or Gonorrhea testing.
Read more
aug. 14, 2020
Acceptable Specimen Collection Devices for SwabOne Testing
Effective August 24, 2020, ACL Laboratories will not be able to perform testing using ESwab™ as a collection device.
ACL Laboratories changed the methodology for Women’s Health SwabOne™ testing for vaginal pathogens effective Thursday, July 16, 2020. This new method is FDA approved and requires specimen (vaginal swab) collected using …
Read more
aug. 05, 2020
ACL Laboratories Discontinues In-House Testing for Viral Loads
Effective immediately, ACL Laboratories has discontinued in-house testing for the following tests:
• BKV Quantitative by PCR (BKVQN)
• BKV Quantitative by PCR, Urine (UKVQN)
• CMV Quantitative by PCR (CMVQN)
• EBV Quantitative by PCR (EBVQN)
• Blood Viral Panel Quantitative by PCR (BVPQN)
The reagent needed for these …
Read more
jul. 23, 2020
2020 Annual Physicians Report
ACL Laboratories maintains an active compliance program that reflects our commitment to conduct business in compliance with all federal, state and local laws. As a participant in federally funded health care programs, ACL Laboratories is required by the Office of Inspector General (OIG) and the US Department of Justice (DOJ) …
Read more
jul. 08, 2020
ACL Laboratories Revises SwabOne Testing Menu
Effective Thursday, July 16, 2020, ACL Laboratories will update the Women’s Health SwabOne™ testing menu for vaginal pathogens.
Read more
may. 14, 2020
ACL Offers Blood/Serology Testing for COVID-19
ACL Laboratories Offers Blood/Serology Testing for COVID-19
Read more
jan. 28, 2020
Important Announcement Novel Coronavirus Jan 2020
Background
A cluster of pneumonia cases was first identified in Wuhan, China in December 2019. The causative agent of cases was later identified as a novel coronavirus that is currently being referred to as 2019-nCoV. It has also been referred to as Wuhan Virus. Within a matter of weeks, the …
Read more
nov. 08, 2019
November 2019 Test Bulletin
ACL Laboratories Changes Methodology for Trace Metal Testing -- 2020 CPT Code Changes -- ACL Laboratories Announces Changes in Instrument Platform for Free Kappa and Free Lambda Light Chains -- New Educational Resource for the Workup of Suspected Myeloproliferative Neoplasm (MPN)
Read more
aug. 19, 2019
September 2019 Test Bulletin
Total and Free PSA - Stability and Transport Requirement Changes
Read more
aug. 13, 2019
ACL Laboratories Makes Significant Changes to Susceptibility Testing
Effective immediately, ACL Laboratories, in conjunction with the Advocate Aurora Health Antimicrobial Stewardship Committee, made a series of significant changes to its microbiology susceptibility testing approaches.
Read more
jun. 28, 2019
July 2019 Test Bulletin
New Medicare Cards: Medicare Beneficiary ID (MBI) System Restrictions -- ACL Laboratories Announces New Test Swabone™ Mycoplasma Genitalium by TMA -- (Test Order Code SWOMG) -- ACL Laboratories Discontinues In-House Testing for Test Order Codes:
HIVGEN, HIVING, TOXPCR and PRVB19 -- ACL Testing Methodology Changes from Rapid Antigen/Culture Techniques to …
Read more
may. 29, 2019
June 2019 Test Bulletin
Heparin Dependent Antibody (PF4IGG, PF4IGR & HDA) Sample Requirements Change -- New Syphilis Total Antibody Assay (Test Order Code SYPT)
Read more
mar. 25, 2019
April 2019 Test Bulletin
Urine Erythrocyte (ERYT) Reference Range and Reporting Range Changes for Asymptomatic MicroHematuria (AMH) -- ACL Laboratories Discontinues In-house Testing for Test Order Codes: CY2C19, CYP2D6, HBVGT, TISSMSI -- ALT (Test Order Code GPT) Reference Range Update
Read more
feb. 28, 2019
March 2019 Test Bulletin
ACL Laboratories Updates Cytogenetics Testing Forms -- ACL Laboratories Offers New Reportable HIV Integrase Drug for Test Order Code HIVING -- Inactivated Code with REF Code
Read more
jan. 30, 2019
February 2019 Test Bulletin
ACL Laboratories Offers Comprehensive Drug Screen – Pain Management Profile 1 (Test Order Code QPNMG1) and deactivates Drug Abuse Panel – Drug Management (Test Order Code DMABUS) -- Pain Management Drug Panel (Test Order Code DRGPM2) -- Pain Management Drug Screen with Interpretation (Test Order Code DRUGPM)
Read more
jan. 10, 2019
January 2019 Test Bulletin
ACL Laboratories Implements New Genetic Test Panel for Prenatal Carrier Screening -- Reference Laboratory Discontinues Test Order Codes JAK2R and REF801 -- Notification of Change: Cigna Coverage Policy for Molecular Microbe Testing -- ACL Laboratories Discontinues Treponema Pallidum Antibody, IgG by IFA (FTA-ABS), Serum (Test Order Code FTABR)
Read more
dec. 03, 2018
December 2018 Test Bulletin
ACL Implements New Methodology for HSV 1 and 2 Qualitative Testing -- Blue Cross Blue Shield Medicaid Currently Following CMS NCD Guidelines for Medicaid Plan -- Swabone™ MYC/Ureaplasma Panel by PCR (Test Order Code SWOMU) replaces Ureaplasma & Mycoplasma Culture (Test Order Code MYURER) -- 2019 CPT Code Changes -- …
Read more
nov. 06, 2018
November 2018 Test Bulletin
ACL Laboratories Revises General Requisition -- CHANGE: Urine Chemistry Storage, Stability, and Transport -- ACL Laboratories Adds Toxin EIA Testing to C. difficile Testing Algorithm -- NT proBNP, Frequently Asked Questions -- Digoxin Specimen Collection/Draw Time -- ACL Laboratories Offers New Quantitative Pain Management Drug Testing Panel
Read more
oct. 03, 2018
October 2018 Test Bulletin
Save time, money, resources, and precious blood…by NOT collecting extra specimens “just in case” -- Addendum to Previously Published September 2018 Test Bulletin Article: Activated Partial Thromboplastin Time (Test Order Code APTT) Reference Range Changes -- ACL Implements New Methodology for HIV-1 Viral Load Testing -- ACL Implements New Methodology …
Read more
